CClinicalTrials.gg
CompletedNCT04790929MuseCogUpdated Jul 25, 2024

Assessing the Effects of the Muse Meditation System on Cognition and Well-being

An interventional study of Muse and Meditation Coaching in Cognitive Change, sponsored by Western University, Canada. Completed at 1 site in Canada. Open to participants aged 18 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-25.

Sponsored by Western University, Canada · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years to 100 Years
Sex
All
01

Study summary

Interaxon markets a head-worn EEG biofeedback device ('Muse') to encourage and aid effective meditation and sleep. This device has been previously shown to improve workplace wellness, fatigue and quality of life, and performance on the Stroop Task. It has also been shown to improve physiological markers associated with improved relaxation. What is not known, is whether the use of the Muse devices can improve cognitive function. In this study, the investigators will examine whether use of the Muse Meditation system by healthy participants, leads to improvements in cognition, sleep quality, mindfulness, improvement in quality of life scores, reduction in perceived stress levels, and improvement in cognitive markers relevant for safety and increased success in the workplace.

Read the detailed description

Meditation is a non-invasive technique that has recently gained significant popularity for its ability to effect positive change on the mind and body. Even a brief (4 sessions) meditation training intervention has been shown to lead to improvements in various areas of cognitive function [1], stress and anxiety, and it has been shown to improve sleep in older adults better than a sleep hygiene course [2]. Mindfulness is now being extensively used in the workplace to promote various aspects of workplace wellness [3], and workplace health and safety [4].

Interaxon markets a head-worn EEG biofeedback device ('Muse') to encourage and aid effective meditation and sleep. This device has been previously shown to improve workplace wellness, fatigue and quality of life, and performance on the Stroop Task. It has also been shown to improve physiological markers associated with improved relaxation.

In this study, the investigators will examine whether use of the Muse Meditation system by healthy participants, leads to improvements in cognition, sleep quality, mindfulness, improvement in quality of life scores, reduction in perceived stress levels, and improvement in cognitive markers relevant for safety and increased success in the workplace.

240 participants will be randomly divided into 3 groups with 80 participants in each group (see below).

Group 1 will use the Muse Meditation system with no coaching.

Group 2 will use the Muse Meditation system with additional online coaching.

Group 3 will be a control group and will not use any of the Muse Meditation systems

On day 1 of the Study, all participants will complete the Cambridge Brain Sciences online cognitive assessment battery, plus a longer questionnaire about stress levels, workplace wellness, quality of life, mindfulness and sleep quality. They will then begin the 6-week study according to their following Group assignments:

Group 1: Regular Muse Meditation System - No Coaching:

Participants will join a 1.5-hour virtual onboarding session where they will complete their first Muse session. Participants will then be asked to use the Muse Meditation system for a minimum of 5 minutes a day (in one or multiple sessions), a minimum of 5 days a week, for 6 weeks. If they wish to use the system more frequently within the 6 weeks, they will be encouraged to do so and will be able to choose between all the styles of meditation available in the Muse Meditation System (Mind, Heart, Breath, Body, Guided or Sleep Journeys). For any challenges that arise, participants will have unlimited access to Muse Customer Care via phone, email, and video where appropriate during normal business hours.

Group 2: Regular Muse Meditation System - Additional Coaching The procedure will be identical to Group 1 above, but in addition, all participants will be asked to join regular online coaching sessions. Participants will be divided into 8 cohorts of 10 people per cohort. Each cohort will be offered group coaching once per week. Coaches will be versed in Mindfulness and how to use Muse. Coaching will take place virtually using Interaxon's Zoom account. Throughout the coaching, all participants will be referred to via their first names or their anonymized login names. In addition, for any challenges that arise, participants will have unlimited access to Muse Customer Care via phone, email, and video where appropriate during normal business hours.

Group 3: Controls The participants in the control group will receive a Muse Device, which they will be free to keep at the end of the study. They will be asked not to open and/or use the Muse device until the entire study is complete. On day 1 of the Study, they will complete the Cambridge Brain Sciences online cognitive assessment battery, plus a longer questionnaire about stress levels, workplace wellness, quality of life, mindfulness, anxiety and depression and sleep quality. At the completion of the study controls will be offered optional, free group coaching sessions if they complete the study requirements.

At the end of Week 6 (at the completion of the main study period), all participants will be reassessed using the Cambridge Brain Sciences online cognitive assessment battery , and the longer questionnaire about stress levels, workplace wellness, quality of life, mindfulness and sleep quality.

All participants will also complete a brief debriefing questionnaire at the end of Week 6, reporting their experiences about the study.

They will again be assessed using the Cambridge Brain Sciences online cognitive assessment battery, and the longer questionnaire about stress levels, workplace wellness, quality of life, mindfulness and sleep quality at the end of Week 12 (6 weeks after completing the main study period).

Hypothesis 1: Using the Muse Meditation system for 6 weeks will yield improvements in cognitive performance on the Cambridge Brain Sciences battery, improvements in self-reported sleep quality (e.g. decreased latency to sleep, improved sleep duration), improvements on measures of mindfulness, improvement in quality of life scores, reduction in perceived stress levels, reduction in anxiety, and improvement in cognitive markers (derived from the Cambridge Brain Sciences scores) relevant for safety and increased success in the workplace. The investigators expect to see these changes in both experimental groups relative to the control group.

Hypothesis 2: These changes will persist well beyond the period of the study and will be detectible at the 12-week follow-up session.

Hypothesis 3: The participants who use the Muse Meditation system and have additional coaching (Group 2), will experience improvements in cognition, stress, anxiety, and other quality of life measures over and above those experienced by those who use the Muse Meditation system with no coaching (Group 1).

02

Conditions studied

  • Cognitive Change
03

In context

Lead sponsor

Western University, Canada is the lead sponsor of 221 studies on the registry; 56 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

The study will be open only to all Hatch Inc employees in Canada.

Exclusion criteria

Exclusion Criteria:

If participants do not own a smart phone

-

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
150 participants (actual)

Study arms

  • Experimental
    Regular Muse Meditation System - No Coaching

    Participants will join a 1.5-hour virtual onboarding session where they will complete their first Muse session. Participants will then be asked to use the Muse Meditation system for a minimum of 5 minutes a day (in one or multiple sessions), a minimum of 5 days a week, for 6 weeks. If they wish to use the system more frequently within the 6 weeks, they will be encouraged to do so and will be able to choose between all the styles of meditation available in the Muse Meditation System (Mind, Heart, Breath, Body, Guided or Sleep Journeys). For any challenges that arise, participants will have unlimited access to Muse Customer Care via phone, email, and video where appropriate during normal business hours.

    Device: Muse

  • Experimental
    Regular Muse Meditation System - Additional Coaching

    The procedure will be identical to Group 1 above, but in addition, all participants will be asked to join regular online coaching sessions. Participants will be divided into 8 cohorts of 10 people per cohort. Each cohort will be offered group coaching once per week. Coaches will be versed in Mindfulness and how to use Muse. Coaching will take place virtually using Interaxon's Zoom account. Throughout the coaching, all participants will be referred to via their first names or their anonymized login names. In addition, for any challenges that arise, participants will have unlimited access to Muse Customer Care via phone, email, and video where appropriate during normal business hours.

    Device: Muse · Behavioral: Meditation Coaching

  • No intervention
    Controls

    The participants in the control group will receive a Muse Device, which they will be free to keep at the end of the study. They will be asked not to open and/or use the Muse device until the entire study is complete. On day 1 of the Study, they will complete the Cambridge Brain Sciences online cognitive assessment battery, plus a longer questionnaire about stress levels, workplace wellness, quality of life, mindfulness, anxiety and depression and sleep quality. At the completion of the study controls will be offered optional, free group coaching sessions if they complete the study requirements.

Interventions

  • DeviceMuse

    Interaxon markets a head-worn EEG biofeedback device ('Muse') to encourage and aid effective meditation and sleep. This device has been previously shown to improve workplace wellness, fatigue and quality of life, and performance on the Stroop Task. It has also been shown to improve physiological markers associated with improved relaxation. Muse has been shown to have an EEG signal comparable to a clinical grade EEG.

  • BehavioralMeditation Coaching

    Participants will be asked to use the Muse Meditation system for a minimum of 5 minutes a day (in one or multiple sessions), a minimum of 5 days a week, for 6 weeks and will be coached in how to do so. Coaches will be versed in Mindfulness and how to use Muse. Coaching will take place virtually using Interaxon's Zoom account.

06

What researchers measure

Primary outcomes

  1. Cognition

    The primary outcome will be scores on the Cambridge Brain Sciences (CBS) cognitive battery The Cambridge Brain Sciences (CBS) battery assesses aspects of memory, attention, planning, and reasoning, using a web-based interface that can be self-administered at home through any internet browser.

    Time frame: 12 weeks

Secondary outcomes

  1. Perceived Stress Scale

    Quality of life will be scoresd on self-reported Perceived Stress Scale.

    Time frame: 12 weeks

  2. Anxiety Questionnaire

    Anxiety will be scored using General Anxiety Disorder 7 Scale

    Time frame: 12 weeks

  3. Depression Questionnaire

    Depression will be measured using will be scored using Patient Health Questionnaire 9

    Time frame: 12 weeks

07

Study locations

1 site
  • Western University
    London, Canada
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04790929
Lead sponsor
Western University, Canada
Collaborators
InteraXon, Inc., Cambridge Brain Sciences
Responsible party
Sponsor
First posted
Mar 10, 2021
Start date
May 1, 2021
Primary completion
May 1, 2022
Completion
Dec 1, 2022
Last update
Jul 25, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion